JADRAN - GALENSKI LABORATORIJ D.D. earnings
Annual earnings per share (EUR per share, as reported)
| Fiscal year | Period end | Diluted EPS | Basic EPS | Filed |
|---|---|---|---|---|
| 2024 | 2024-12-31 | €21.59 | €21.59 | 2026-06-19T15:02:31Z |
| 2023 | 2023-12-31 | €16.41 | €16.41 | 2026-06-19T15:02:31Z |
Revenue & profit (EUR)
| Concept | 2024 | 2023 |
|---|---|---|
| Revenue | €246.1M | €208.2M |
| Profit for the year | €26.6M | €19.6M |
Methodology
Earnings per share comes from ifrs-full:DilutedEarningsLossPerShare /
ifrs-full:BasicEarningsLossPerShare; revenue from
ifrs-full:Revenue and profit from ifrs-full:ProfitLoss,
as tagged in JADRAN - GALENSKI LABORATORIJ D.D.'s ESEF annual reports (source:
filings.xbrl.org).
Figures are in EUR, as reported. Not investment advice.